Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium

INTRODUCTION: As integrase inhibitors become available in low‐ and middle‐income countries (LMICs), they offer the potential to expand extremely limited treatment options available to children and adolescents. In LMICs, only small numbers have used raltegravir, primarily as part of third‐line regime...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Int AIDS Soc
Main Authors: Patten, Gabriela, Puthanakit, Thanyawee, McGowan, Catherine C, Wools‐Kaloustian, Kara, Hazra, Rohan, Pinto, Jorge A, Machado, Daisy, Succi, Regina, Sohn, Annette H, Rabie, Helena, Musick, Beverly, Davies, Mary‐Ann
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Short Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7387110/
https://ncbi.nlm.nih.gov/pubmed/32722897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jia2.25580
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados